News

Photoactivable drugs are activated when irradiated by a beam of light—via an optical fiber—thus generating a controlled and ...
Scientists discovered a hidden CB₁ receptor pocket and engineered a drug to exploit it, offering promise of safer, more ...
Global AT2R-targeted drug development remains nascent, with only a few competitors like Lilly-partnered CFTX-1554 (Phase I).
Photoactivable drugs are activated when irradiated by a beam of light — via an optical fibre — thus generating a controlled ...
A new wireless, battery-free photopharmacology protocol, based on the local and controlled release of light-activable drugs, proves its efficacy in ...
The phase 2a trial showed rapid onset as well as long-lasting pain reduction with Algiax's allosteric GABAA-receptor modulator ... there were no central nervous system side effects – such ...
Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...
Mount Sinai researchers have discovered distinct roles for two dopamine receptors located on nerve cells within the portion ...